D-LAK-120A (D-LAK) peptide
Not For Human Use, Lab Use Only.
Cat.#: 318945
Special Price 334.0 USD
-
Product Name
D-LAK-120A (D-LAK) peptide
-
Documents
Batch to batch variation of the purity
-
Sequence Shortening
H-KKLALALAKKWLALAKKLALALAKK-NH2 (All D-type amino acids)
-
Sequence
H-Lys-Lys-Leu-Ala-Leu-Ala-Leu-Ala-Lys-Lys-Trp-Leu-Ala-Leu-Ala-Lys-Lys-Leu-Ala-Leu-Ala-Leu-Ala-Lys-Lys-NH2 (All D-type amino acids)
-
Length (aa)
25
-
Peptide Purity (HPLC)
95.18%
-
Molecular Formula
C131H237N35O25
-
Molecular Weight
2702.49
-
Source
Synthetic
-
Form
Powder
-
Description
D-LAK-120A (D-LAK; KKLALALAKKWLALAKKLALALAKK-NH2) a cationic antimicrobial peptide. The D-LAK peptides were cationic and amphipathic, with angle subtended by positively charged lysine residues when the peptide adopts an idealized α-helix conformation. D-LAK showed inhibitory action against M. smegmatis by acting on the mycobacterial cell wall and leading to pore formation (membranolytic pathway) in vitro. D-LAK peptide demonstrated enhanced cytotoxicity in A549, H358, H1975, and HCC827 cell lines with inhibitory concentrations between 4.0 and 5.5 μM. D-LAK induced lung cancer cell apoptosis and arrested cells in the S phase (DNA synthesis) of cell cycle. D-LAK inhibited single cell proliferation and cancer cell migration in vitro. The tumor reduction observed in the 3D spheroid assay further suggests the potential use of D-LAK as an anticancer agent for NSCLC treatment.
-
Storage Guidelines
Normally, this peptide will be delivered in lyophilized form and should be stored in a freezer at or below -20 °C. For more details, please refer to the manual:Handling and Storage of Synthetic Peptides
-
References
- Suyash M. Patil, Nitesh K. Kunda, Anticancer activity of D-LAK-120A, an antimicrobial peptide, in non-small cell lung cancer (NSCLC), Biochimie, 2022, ISSN 0300-9084, https://doi.org/10.1016/j.biochi.2022.06.011.
-
About TFA salt
Trifluoroacetic acid (TFA) has a significant impact on peptides due to its role in the peptide synthesis process.
TFA is essential for the protonation of peptides that lack basic amino acids such as Arginine (Arg), Histidine (His), and Lysine (Lys), or ones that have blocked N-termini. As a result, peptides often contain TFA salts in the final product.
TFA residues, when present in custom peptides, can cause unpredictable fluctuations in experimental data. At a nanomolar (nM) level, TFA can influence cell experiments, hindering cell growth at low concentrations (as low as 10 nM) and promoting it at higher doses (0.5–7.0 mM). It can also serve as an allosteric regulator on the GlyR of glycine receptors, thereby increasing receptor activity at lower glycine concentrations.
In an in vivo setting, TFA can trifluoroacetylate amino groups in proteins and phospholipids, inducing potentially unwanted antibody responses. Moreover, TFA can impact structure studies as it affects spectrum absorption.
-
Molar Concentration Calculator
-
Dilution Calculator
-
Percent Concentration Calculator
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
Related Products / Services
• Peptide Services: NovoPro's peptide synthesis services include standard chemical peptide synthesis, peptide modification, peptide libraries, and recombinant peptide expression.
• Standard Peptide Synthesis: NovoPro offers quality peptides at the most competitive prices in the industry, starting at $3.20 per amino acid. NovoPro provides PepBox – Automatic Quote Tool for online price calculation.
• Peptide Modifications: NovoPro offers a wide range of peptide modification services including isotope labeling (2H, 15N, and 13C), multiple disulfide bonds, multiple phosphorylations, KLH, BSA, ovalbumin, amidation, acetylation, biotin, FITC, etc.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"